ArticleYonsei medical journal2019

MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.

Qin Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.